Skip to search formSkip to main contentSkip to account menu

EXP561

Known as: EXP 561, EXP-561 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Bridged Bicyclo Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Pharmacological properties of EXP 561, a potential antidepressant drug
The compound EXP 561 (1-amino-4-phenylbicyclo-[2, 2, 2]-octane), an inhibitor of the noradrenaline (NA), 5-hydroxytryptamine (5… 
1992
1992
Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
Highly Cited
1988
Highly Cited
1988
Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor.
Fluoxetine, a selective inhibitor of serotonin uptake, is clinically useful in treating depression and may be useful for… 
1988
1988
Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Highly Cited
1982
Highly Cited
1982
Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine
1978
1978
Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in rats.
EXP 561, 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate, antagonized brain serotonin depletion by p… 
1978
1978
Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in rats.
EXP 561, 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate, antagonized brain serotonin depletion by p… 
1977
1977
Blockade of monoamine uptake by 1-amino-4-phenylbicyclo[2,2,2]octane (EXP 561) in rat brain and heart
1969
1969
The evaluation of a new animal method for the prediction of clinical anti-depressant activity.
1967
1967
A clinical-pharmacological study with EXP 561.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)